What people are saying - Write a review
We haven't found any reviews in the usual places.
The EORTC Phase II Studies in Advanced
CANCER OF THE PROSTATE
Some Observations on Incidence and Natural History
74 other sections not shown
Other editions - View all
activity adenocarcinoma adenoma advanced prostatic cancer androgen receptors aspiration biopsy assay benign prostatic benign prostatic hyperplasia biochemical bladder BM-PAP bone metastases bone scan CD CD chemotherapy Clin correlation cryosurgery cyproterone acetate cytologic Cytoxan detection diagnosis diethylstilbestrol differentiated disease dose effect elevated endocrine therapy epithelial cells epithelium Estracyt estramustine estrogen evaluation G.P. Murphy Gleason histochemical histological hormonal therapy human prostatic immunological irradiation kidney lesions levels lymph node malignant marker method months National Prostatic Cancer normal nuclear orchiectomy patients with advanced patients with prostatic pelvic performance status perineal plasma prednimustine prognostic progression prostate gland prostatic acid phosphatase prostatic adenocarcinoma prostatic cancer Prostatic Cancer Project prostatic carcinoma prostatic tissue protein Protocol radiation therapy radiotherapy renal cancer renal cell carcinoma reported response retropubic Se-PAP significant steroid stroma surgical survival Table technique testosterone trial tumor Urol Urological VACURG vitro